HFS
FENC icon

Hughes Financial Services’s Fennec Pharmaceuticals FENC Stock Holding History

Hughes Financial Services’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$763 Hold
71
– – ﹤0.01% 981
2026
Q1 		$437 Sell
71
-26
-27% -$201 ﹤0.01% 957
2025
Q4 		$747 Sell
97
-11
-10% -$90 ﹤0.01% 804
2025
Q3 		$829 Hold
108
– – ﹤0.01% 769
2025
Q2 		$881 Hold
108
– – ﹤0.01% 732
2025
Q1 		$597 Buy
+108
New +$694 ﹤0.01% 798

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Hughes Financial Services's FENC Position: Q2 2026 in Review

Hughes Financial Services held its Fennec Pharmaceuticals (FENC) position steady in Q2 2026 at 71 shares worth $763. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Hughes Financial Services first reported a position in FENC in Q1 2025 and has held it in 6 quarters since. The position peaked at $881 in Q2 2025. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Hughes Financial Services held 71 shares of Fennec Pharmaceuticals worth $763 as of Q2 2026.
  • Hughes Financial Services left its Fennec Pharmaceuticals share count unchanged in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #981 holding.
  • Hughes Financial Services first reported a position in Fennec Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Hughes Financial Services's Fennec Pharmaceuticals position peaked at $881 in Q2 2025.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.